X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 55 filers reported holding X4 PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,832,913 | -16.5% | 2,599,003 | +48.6% | 0.88% | +1.6% |
| Q2 2023 | $3,393,066 | +87.1% | 1,749,003 | -4.2% | 0.86% | +28.6% |
| Q4 2022 | $1,813,181 | -25.3% | 1,825,963 | +28.7% | 0.67% | -13.0% |
| Q3 2022 | $2,426,000 | +808.6% | 1,418,461 | +412.2% | 0.77% | +671.0% |
| Q2 2022 | $267,000 | -44.9% | 276,909 | 0.0% | 0.10% | -37.5% |
| Q1 2022 | $485,000 | -23.5% | 276,909 | 0.0% | 0.16% | -16.2% |
| Q4 2021 | $634,000 | -85.1% | 276,909 | -65.6% | 0.19% | -85.9% |
| Q3 2021 | $4,256,000 | -18.6% | 804,597 | 0.0% | 1.36% | +4.4% |
| Q2 2021 | $5,230,000 | -24.5% | 804,597 | 0.0% | 1.30% | -7.5% |
| Q1 2021 | $6,928,000 | – | 804,597 | – | 1.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |